BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36943365)

  • 1. Comparisons of SLE-DAS and SLEDAI-2K and classification of disease activity based on the SLE-DAS with reference to patient-reported outcomes.
    Onishi A; Tsuji H; Takase Y; Nakakubo Y; Iwasaki T; Kozuki T; Yoshida T; Shirakashi M; Onizawa H; Hiwa R; Kitagori K; Akizuki S; Nakashima R; Yoshifuji H; Tanaka M; Morinobu A
    Rheumatology (Oxford); 2023 Dec; 62(12):3909-3915. PubMed ID: 36943365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparison of the Correlation of Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) with Health-Related Quality of Life.
    Lai NS; Lu MC; Chang HH; Lo HC; Hsu CW; Huang KY; Tung CH; Hsu BB; Wu CH; Koo M
    J Clin Med; 2021 May; 10(10):. PubMed ID: 34063379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation and verification of the Japanese version of the systemic lupus erythematosus symptom checklist for patient quality of life.
    Doi H; Ohmura K; Tabuchi Y; Hashimoto M; Takase Y; Inaba R; Kozuki T; Iwasaki T; Taniguchi M; Kitagori K; Akizuki S; Murakami K; Nakashima R; Yoshifuji H; Yamamoto W; Tanaka M; Akio M
    Lupus; 2021 Jun; 30(7):1108-1115. PubMed ID: 33779381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity.
    Jesus D; Matos A; Henriques C; Zen M; Larosa M; Iaccarino L; Da Silva JAP; Doria A; Inês LS
    Ann Rheum Dis; 2019 Mar; 78(3):365-371. PubMed ID: 30626657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of disease activity with depression and anxiety in systemic lupus erythematosus: A comparison of SLEDAI-2K and SLE-DAS.
    Yang L; Gu B; Wang X; Ren Q; Shen M; Su D
    Rheumatology (Oxford); 2024 Feb; ():. PubMed ID: 38305645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between physicians' global assessment of disease activity and patient-reported outcomes in patients with systemic lupus erythematosus: A longitudinal study.
    Louthrenoo W; Kasitanon N; Morand E; Kandane-Rathnayake R
    Lupus; 2021 Sep; 30(10):1586-1595. PubMed ID: 34192957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS).
    Abdelhady EI; Rabie M; Hassan RA
    Clin Rheumatol; 2021 Nov; 40(11):4553-4558. PubMed ID: 34142298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of systemic lupus erythematosus (SLE) Disease Activity Score and SLE Disease Activity Index 2000-based remission states in patients with SLE on damage accrual.
    Chitpet P; Chaiamnuay S; Narongroeknawin P; Asavatanabodee P; Leosuthamas P; Pakchotanon R
    Int J Rheum Dis; 2023 Dec; 26(12):2509-2516. PubMed ID: 37875327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) enables accurate and user-friendly definitions of clinical remission and categories of disease activity.
    Jesus D; Larosa M; Henriques C; Matos A; Zen M; Tomé P; Alves V; Costa N; Le Guern V; Iaccarino L; Costedoat-Chalumeau N; Doria A; Inês LS
    Ann Rheum Dis; 2021 Dec; 80(12):1568-1574. PubMed ID: 34407927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased frequency of hospital admissions with active systemic lupus erythematosus disease activity defined by two different disease activity indices: A cohort study.
    Wang CL; Koo M; Hsu CW; Lu MC
    Lupus; 2023 Jun; 32(7):864-872. PubMed ID: 37165549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of constitutional symptoms to the SLEDAI-2K improves overall disease activity assessment: A pilot study.
    Anderson EW; Sansone M; Shah B; Kline M; Franchin G; Aranow C; Mackay M
    Lupus; 2024 Jul; 33(8):840-850. PubMed ID: 38664230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hindi LupusPRO: cross cultural validation of disease specific patient reported outcome measure of lupus.
    Pinto B; Jolly M; Dhooria A; Grover S; Raj JM; Devilliers H; Sharma A
    Lupus; 2019 Nov; 28(13):1534-1540. PubMed ID: 31635557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of an administrative algorithm for SLE disease severity to clinical SLE Disease Activity Index scores.
    Speyer CB; Li D; Guan H; Yoshida K; Stevens E; Jorge AM; Everett BM; Feldman CH; Costenbader KH
    Rheumatol Int; 2020 Feb; 40(2):257-261. PubMed ID: 31784790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of a New Instrument for the Measurement of Systemic Lupus Erythematosus Disease Activity: The SLE-DAS.
    Koo M; Lu MC
    Medicina (Kaunas); 2023 Nov; 59(12):. PubMed ID: 38138199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of hospital admissions in patients with active systemic lupus erythematosus (SLE) classified according to two different SLE disease activity indices: a prospective cohort study.
    Lu MC; Hsu CW; Koo M; Lai NS
    Clin Exp Rheumatol; 2023 Jul; 41(7):1409-1416. PubMed ID: 36377575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of SLE-DAS in assessing disease activity in patients with systemic lupus erythematosus: a single-centre retrospective study.
    Ma J; Zhang L; Yan M; Liu Z; Xue L
    Lupus Sci Med; 2024 Jun; 11(1):. PubMed ID: 38862157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Arabic LupusPRO: A Cross-Cultural Validation of a Disease-Specific Patient-Reported Outcome Tool for Quality of Life in Lupus Patients.
    Elkaraly NE; Nasef SI; Omar AS; Fouad AM; Jolly M; Mohamed AE
    Lupus; 2020 Nov; 29(13):1727-1735. PubMed ID: 32878556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.
    Bourré-Tessier J; Clarke AE; Mikolaitis-Preuss RA; Kosinski M; Bernatsky S; Block JA; Jolly M
    J Rheumatol; 2013 Aug; 40(8):1327-33. PubMed ID: 23772082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): data from the Peruvian Almenara Lupus Cohort.
    Ugarte-Gil MF; Gamboa-Cardenas RV; Reátegui-Sokolova C; Pimentel-Quiroz VR; Zeña-Huancas P; Elera-Fitzcarrald C; Garcia-Hirsh S; Gil L; Pastor-Asurza CA; Rodriguez-Bellido Z; Merrill J; Askanase AD; Alarcon G; Perich-Campos RA
    Lupus Sci Med; 2020 Oct; 7(1):. PubMed ID: 33046557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of systemic lupus erythematosus responder index for detecting clinician-rated responders in patients with active systemic lupus erythematosus.
    Leosuthamas P; Narongroeknawin P; Chaiamnuay S; Asavatanabodee P; Pakchotanon R
    Int J Rheum Dis; 2023 Apr; 26(4):667-672. PubMed ID: 36802112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.